Kazuya Oshima
Overview
Explore the profile of Kazuya Oshima including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
1020
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hashimoto K, Kitaguchi K, Tateiwa D, Oshima K, Wada E
Cureus
. 2025 Jan;
16(12):e76097.
PMID: 39840186
Introduction: Lumbar canal stenosis (LCS) is a common degenerative lumbar spinal disease (DLSD) widely treated by decompression surgery, also known as laminectomy. Few cases have been observed where DLSD has...
2.
Oshima K, Sugano Y, Yoshida A, Uegami W, Van Sickels N, Kobayashi T, et al.
IDCases
. 2024 Sep;
38:e02078.
PMID: 39309038
can lead to bacteremia in elderly individuals with underlying conditions, primarily from cellulitis. Although rare, mediastinal abscesses can develop from anatomical anomalies, post-thoracic surgery, esophageal rupture, or inflammation in the...
3.
Morioka H, Kawano H, Takagi T, Abe S, Ogata N, Iwase S, et al.
J Orthop Sci
. 2021 Dec;
28(2):446-452.
PMID: 34906401
Background: In order to improve cancer care in Japan further, it is now required for orthopaedic surgeons to get actively involved in managing locomotive organs such as bones, muscles and...
4.
Outani H, Kakunaga S, Hamada K, Takenaka S, Imura Y, Nagata S, et al.
Mol Clin Oncol
. 2019 Jul;
11(2):151-156.
PMID: 31281649
Synovial sarcoma (SS) is considered to be a chemosensitive, soft tissue sarcoma. Therefore, neoadjuvant and/or adjuvant chemotherapy (N/AC) is used for the treatment of high-risk SS patients. However, the role...
5.
Imura Y, Takenaka S, Kakunaga S, Nakai T, Wakamatsu T, Outani H, et al.
Int Orthop
. 2019 Apr;
43(7):1741-1747.
PMID: 31011764
Background: Few studies have described the characteristics and prognostic factors of elderly patients with osteosarcoma. We retrospectively investigated clinico-pathological features and prognostic factors in osteosarcoma patients > 40 years old....
6.
Tateiwa D, Oshima K, Nakai T, Imura Y, Tanaka T, Outani H, et al.
J Orthop Sci
. 2018 Nov;
24(2):347-352.
PMID: 30482604
Background: The development of effective chemotherapy regimens and molecular targeting agents are improving the overall survival rates in patients with cancer. However, patients who are non-ambulatory due to metastatic epidural...
7.
Tamiya H, Hagizawa H, Nakai T, Imura Y, Tanaka T, Oshima K, et al.
Case Rep Orthop
. 2018 Nov;
2018:7862516.
PMID: 30402317
Zoledronate or denosumab treatment is beneficial for cancer patients with bone metastasis. However, each agent may trigger atypical femoral fractures. Incomplete atypical femoral fractures can be successfully treated with prophylactic...
8.
Outani H, Akita H, Nakai T, Takada R, Imura Y, Tanaka T, et al.
Pancreas
. 2018 Jul;
47(7):e43-e46.
PMID: 29985850
No abstract available.
9.
Ukon Y, Tanaka T, Nagata S, Hagizawa H, Imura Y, Tamiya H, et al.
Oncol Lett
. 2018 May;
15(5):7909-7913.
PMID: 29731908
Calcific myonecrosis is a rare soft tissue condition. The first case was reported in 1960, however, the precise pathophysiology of calcific myonecrosis remains unclear. The disease was thought to arise...
10.
Oshima K, Sakaura H, Iwasaki M, Oka K, Sugamoto K, Yoshikawa H
JBJS Case Connect
. 2017 Dec;
2(3):e41.
PMID: 29252539
No abstract available.